Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.76 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.76 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.76 |
| ▸ | MAPT | P10636 | 2/20 | 0.73 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.62 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.62 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.62 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.62 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.62 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.62 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.62 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.60 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.60 |
| ▸ | FABP3 | P05413 | 1/20 | 0.58 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.58 |
| ▸ | CDC25A | P30304 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30652127 | 1.00 | SMN1; SMN2 (0.76) | SMN1; SMN2NR5A2NR5A1MAPTLPAR6 | |
| SCHEMBL29482586 | 1.00 | SMN1; SMN2 (0.76) | SMN1; SMN2NR5A2NR5A1MAPTLPAR6 | |
| Lysophosphatidylcholine SCHEMBL29651472 | 1.00 | SMN1; SMN2 (0.76) | SMN1; SMN2NR5A2NR5A1MAPTLPAR6 | |
| SCHEMBL9015289 | 1.00 | SMN1; SMN2 (0.76) | SMN1; SMN2NR5A2NR5A1MAPTLPAR6 | |
| Lysophosphatidylcholine SCHEMBL19787878 | 1.00 | SMN1; SMN2 (0.76) | SMN1; SMN2NR5A2NR5A1MAPTLPAR6 | |
| SCHEMBL11131776 | 1.00 | SMN1; SMN2 (0.76) | SMN1; SMN2NR5A2NR5A1MAPTLPAR6 | |
| SCHEMBL31577414 | 1.00 | SMN1; SMN2 (0.76) | SMN1; SMN2NR5A2NR5A1MAPTLPAR6 | |
| SCHEMBL31122371 | 1.00 | SMN1; SMN2 (0.76) | SMN1; SMN2NR5A2NR5A1MAPTLPAR6 | |
| SCHEMBL19065066 | 1.00 | SMN1; SMN2 (0.76) | SMN1; SMN2NR5A2NR5A1MAPTLPAR6 | |
| SCHEMBL30651187 | 1.00 | SMN1; SMN2 (0.76) | SMN1; SMN2NR5A2NR5A1MAPTLPAR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5255042-A | — | — | None | — | — | JP | disclosed |
| JP-2169507-A | — | — | None | — | — | JP | disclosed |
| CN-118924841-A | Application of polygonatum odoratum extract in preparation of medicine for improving type 2 diabetes | 浙江树人学院 | 2024-11-12 | — | — | CN | disclosed |
| US-20230226031-A1 | Formulated and/or Co-Formulated Liposome Compositions Containing Immunogenic Cell Death (ICD) Inducing Prodrugs Useful In The Treatment of Cancer and Methods Thereof | NAMMI THERAPEUTICS, INC. | 2023-07-20 | — | — | US | disclosed |
| EP-3606534-B1 | PHOSPHOLIPID DERIVATIVES AND THEIR USE AS MEDICAMENTS | USTAV MOLEKULARNI GENETIKY AV CR V V I (CZ) | 2021-05-12 | — | — | EP | disclosed |
| US-20180104364-A1 | TEXAPHYRIN-PHOSPHOLIPID CONJUGATES AND METHODS OF PREPARING SAME | UNIVERSITY HEALTH NETWORK (CA) | 2018-04-19 | — | — | US | disclosed |
| JP-H05255042-A | POWDERY MAKE-UP COSMETIC | KANEBO LTD | 1993-10-05 | — | — | JP | disclosed |
| JP-H02169507-A | COSMETIC | KANEBO LTD | 1990-06-29 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230226031-A1 | Formulated and/or Co-Formulated Liposome Compositions Containing Immunogenic Cell Death (ICD) Inducing Prodrugs Useful In The Treatment of Cancer and Methods Thereof | LCP2, LITAF, BAD | SMN1; SMN2 1768/4885NR5A2 3931/4885NR5A1 4401/4885 |
| US-20180104364-A1 | TEXAPHYRIN-PHOSPHOLIPID CONJUGATES AND METHODS OF PREPARING SAME | PLTP, PHOSPHO1, TEX13A | SMN1; SMN2 2014/4885NR5A2 4189/4885NR5A1 4117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.